Expression profiling and mutational analysis identifies a new subgroup of normal karyotype AML.

被引：0
|
作者：
Debernardi, S [1 ]
Smith, M [1 ]
Lillington, DM [1 ]
Chaplin, T [1 ]
Rohatiner, A [1 ]
Lister, A [1 ]
Young, BD [1 ]
机构：
[1] St Bartholomews Hosp, Canc Res UK, Dept Med Oncol, London, England
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1322
引用
收藏
页码：364A / 364A
页数：1
相关论文
共 50 条
  • [1] Expression Profiling of a Hemopoietic Cell Survival Transcriptome Identifies a Functional Prognostic Gene Signature in Normal Karyotype AML.
    Guthridge, Mark
    Thomas, Daniel
    Barry, Emma F.
    Chung, Kok H.
    McClure, Barbara J.
    To, L. Bik
    Goodall, Greg
    Speed, Terry P.
    Osato, Motomi
    Haylock, David
    Nilsson, Susie
    D'Andrea, Richard
    Lopez, Angel
    Powell, Jason A.
    BLOOD, 2009, 114 (22) : 647 - 647
  • [2] Gene Expression Analysis of Independent Data Sets Identifies HBG1 to Be Associated with Outcome in Cytogenetically Normal AML.
    Bullinger, Lars
    Hielscher, Thomas
    Metzeler, Klaus H.
    Botzenhardt, Ursula
    Heinrich, Sabrina
    Krauter, Juergen
    Schlenk, Richard F.
    Buske, Christian
    Doehner, Konstanze
    Benner, Axel
    Ganser, Arnold
    Doehner, Hartmut
    BLOOD, 2009, 114 (22) : 1025 - 1025
  • [3] Gene expression profiling identifies a prognostically favorable subgroup in AML independent of cytogenetic stratification.
    Schoch, C
    Kern, W
    Kohlmann, A
    Hiddemann, W
    Merk, S
    Schnittger, S
    Haferlach, T
    BLOOD, 2004, 104 (11) : 164A - 165A
  • [4] Gene expression profiling to investigate age related aetiology of AML.
    Mills, KI
    Woodward, EL
    Gilkes, AF
    Burnett, AK
    BLOOD, 2003, 102 (11) : 376A - 376A
  • [5] Gene mutations as predicitive markers for postremission therapy in younger adults with normal karyotype AML.
    Schlenk, Richard F.
    Corbacioglu, Andrea
    Krauter, Jurgen
    Bullinger, Lars
    Morgan, Michael
    Spaeth, Daniela
    Schaefer, Irina
    Frohling, Stefan
    Ganser, Arnold
    Dohner, Hartmut
    Dohner, Konstanze
    BLOOD, 2006, 108 (11) : 6A - 6A
  • [6] Gene Expression Profiling In Leukemic Stem Cell-Enriched AML CD34+ Cell Fraction Identifies Target Genes That Predict Prognosis In Normal Karyotype AML
    Woolthuis, Carolien M.
    de Jonge, Hendrik J. M.
    Vos, Annet Z.
    Mulder, Andre B.
    van den Berg, Eva
    Kluin, P. M.
    van der Weide, Karen
    De Bont, Evelina S.
    Huls, Geert A.
    Vellenga, Edo
    Schuringa, Jan J.
    BLOOD, 2010, 116 (21) : 419 - 420
  • [7] Gene Expression Profiling in AML with Normal Karyotype: A Multicenter Study Investigating Molecular Markers in 252 Cases
    Kohlmann, Alexander
    Bullinger, Lars
    Thiede, Christian
    Schaich, Markus
    Schnittger, Susanne
    DohnerMd, Konstanze
    Dugas, Martin
    Dohner, Hartmut
    Ehninger, Gerhard
    Haferlach, Torsten
    BLOOD, 2008, 112 (11) : 278 - 279
  • [8] Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML
    de Jonge, H. J. M.
    Woolthuis, C. M.
    Vos, A. Z.
    Mulder, A.
    van den Berg, E.
    Kluin, P. M.
    van der Weide, K.
    de Bont, E. S. J. M.
    Huls, G.
    Vellenga, E.
    Schuringa, J. J.
    LEUKEMIA, 2011, 25 (12) : 1825 - 1833
  • [9] Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML
    H J M de Jonge
    C M Woolthuis
    A Z Vos
    A Mulder
    E van den Berg
    P M Kluin
    K van der Weide
    E S J M de Bont
    G Huls
    E Vellenga
    J J Schuringa
    Leukemia, 2011, 25 : 1825 - 1833
  • [10] Coinhibitory Expression Profiling of AML Blasts Identifies HVEM as Prognostic Marker in AML
    Lichtenegger, Felix S.
    Kondla, Isabell
    Krempasky, Michael
    Weber, Anna L.
    Schneider, Stephanie
    Spiekermann, Karsten
    Braess, Jan
    Hiddemann, Wolfgang
    Subklewe, Marion
    BLOOD, 2013, 122 (21)
12345